RxDoctor Payments Data

Anna Farago

Hematology & Oncology · Boston, MANPI 1114185527

Payments from drug & device makers

$852,425in general payments, 2019–2025

Across 178 payments — averaging $4788.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$415K
  • Bayer$153K
  • Genentech, Inc.$140K
  • AbbVie$74K
  • Amgen$33K
  • Boehringer Ingelheim International GmbH$14K
  • plus $24K from 7 others
$4,711in research payments, 2019–2025

Across 11 payments — averaging $428.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$5K

What the payments were for

  • Consulting fees$77,49676%
  • Speaking & faculty fees$4,6045%
  • Travel & lodging$18,38918%
  • Food & beverage$1,4791%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$852,425 in reported general payments places this provider in the 80th percentile of 374 hematology & oncology providers in Massachusetts.

See all hematology & oncology providers in Massachusetts

Other hematology & oncology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →